What is JPatible?
JPatible offers accessible and affordable genetic screening solutions tailored to Ashkenazic, Sephardic, and Mizrahi populations, identifying over 200 prevalent genetic diseases. Their service model includes at-home saliva collection, detailed diagnostic reports, and couple compatibility matching, all while prioritizing client privacy. By empowering individuals and couples with genetic insights, JPatible facilitates informed family planning decisions to mitigate the risk of hereditary conditions in future generations. The company also facilitates access to genetic counseling resources.
How much funding has JPatible raised?
JPatible has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
What's next for JPatible?
With significant Series B/C stage backing, JPatible is poised for strategic growth and market penetration. The recent capital infusion is expected to fuel the expansion of their service offerings, enhance their technological infrastructure for genetic analysis and matching, and broaden their outreach to Jewish communities globally. This investment underscores a strong market confidence in JPatible's model for addressing critical genetic health needs and solidifying its position as a leader in specialized genetic services.
See full JPatible company page
